Skip to main content

Live Amgen Inc Share Price Chart

O H L

Amgen Inc Performance Overview

Days Range
▼
$405.81Low
$415.11High

Markets Today

Previous Close$406.04
Open$405.81
Volume1,795,941
Day's Range$405.81 - $415.11
52W Range$269.77 - $447.03
Market Cap$219.52 B

Historical Performance

1M Returns-5.84
3M Returns+15.71
6M Returns+17.40
1Y Returns+51.88
5Y Returns+94.55
10Y Returns+138.93

Amgen Inc Fundamentals

Market Cap$219.52 B
Dividend yield2.48
PE Ratio25.22
PEG RatioN/A
Revenue$36.75 B
ROE TTM1.06
EPS TTM$16.10
Quarterly Earnings Growth YOYN/A
PB Ratio18.78
EBITDA$14.25 B
Profit Margin20.98
Market Cap$219.52 B
Dividend yield2.48
PE Ratio25.22
PEG RatioN/A
Revenue$36.75 B
ROE TTM1.06
EPS TTM$16.10
Quarterly Earnings Growth YOYN/A
PB Ratio18.78
EBITDA$14.25 B
Profit Margin20.98

Amgen Inc Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$8.15 B$9.18 B$9.56 B$9.87 B$8.62 B$10.05 B
Gross Profit +$5.18 B$6.17 B$6.47 B$6.89 B$5.87 B$7.24 B
Operating Income $1.18 B$2.66 B$2.53 B$2.72 B$2.67 B$3.51 B
EBITDA $2.56 B$4.00 B$3.83 B$3.85 B$3.78 B$4.63 B
Interest Expense -$723.00 M-$694.00 M-$685.00 M-$653.00 M-$657.00 M-$673.00 M
Depreciation $1.39 B$1.34 B$1.31 B$1.13 B$1.12 B$1.11 B
Income Before Tax $1.97 B$1.57 B$3.92 B$1.51 B$2.08 B$2.77 B
Income Tax Expense $243.00 M$136.00 M$705.00 M$181.00 M$265.00 M$393.00 M
Net Income +$1.73 B$1.43 B$3.22 B$1.33 B$1.82 B$2.38 B
Net Profit Margin 21.23%15.6%33.65%13.51%21.11%23.62%

Amgen Inc Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $33.58 B$33.68 B$33.84 B$34.02 B$34.03 B$34.08 B
Reserve & Surplus -$27.37 B-$26.25 B-$24.22 B-$25.36 B-$24.84 B-$22.39 B
Non-Current Liabilities $60.15 B$59.99 B$58.73 B$56.44 B$58.36 B$58.45 B
Current Liabilities $23.01 B$20.48 B$21.79 B$25.49 B$24.95 B$25.50 B
Total Liabilities $83.16 B$80.47 B$80.52 B$81.93 B$83.31 B$83.95 B
Fixed Assets $32.41 B$31.47 B$30.36 B$30.19 B$29.59 B$29.03 B
Current Assets $26.93 B$26.73 B$27.89 B$29.06 B$31.48 B$34.96 B
Total Assets $89.37 B$87.90 B$90.14 B$90.59 B$92.50 B$95.64 B

Amgen Inc Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income $1.73 B$1.43 B$3.22 B$1.33 B$1.82 B$2.38 B
Operating Cash Flow $1.39 B$2.28 B$4.68 B$1.60 B$2.19 B$4.00 B
Investing Cash Flow -$447.00 M-$389.00 M-$414.00 M-$693.00 M-$716.00 M-$569.00 M
Financing Cash Flow -$4.11 B-$2.67 B-$2.85 B-$1.23 B$1.44 B-$1.48 B
Change in Cash -$3.16 B-$782.00 M$1.42 B-$316.00 M$2.91 B$1.95 B

Amgen Inc Peer Comparison

CompanyMarket Cap5 Years Return %PE RatioProfit Margin %Dividend Yield %
ABBV
$468.50B145.40%74.986.92%2.61%
GILD
$185.61B114.36%0.0028.90%2.19%
VRTX
$132.40B186.89%30.3932.94%0.00%
AZN
$255.22B41.84%NA21.11%NA
MRK
$365.09B102.81%118.1928.09%2.30%
LLY
$1.05T422.73%39.6731.67%0.59%
PFE
$161.93B-34.20%37.5812.48%6.05%
BMY
$125.63B5.05%13.5414.64%4.10%
MRNA
$77.78B-51.36%0.00-145.16%0.00%
JNJ
$652.31B66.22%31.3928.46%1.98%

Amgen Inc Return Calculator

The Amgen Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$18,872
Invested Amount$10,000
Est. Returns$8,872
Invest in USA Stock Today

About Amgen Inc

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

FAQs

Amgen Inc (AMGN) share price as of September 26, 2026 is $402.19. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Amgen Inc (AMGN) Share by opening an international trading account with Angel One.
Purchasing Amgen Inc (AMGN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Amgen Inc (AMGN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Amgen Inc (AMGN) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Amgen Inc on September 26, 2026, is $219.52 B.
Amgen Inc operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Amgen Inc (AMGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91